Literature DB >> 18206206

Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration.

Haoyu Chen1, Zhenglin Yang, Daniel Gibbs, Xian Yang, Vincent Hau, Peiquan Zhao, Xiang Ma, Jiexi Zeng, Ling Luo, Erik Pearson, Ryan Constantine, Yuuki Kaminoh, Jennifer Harmon, Zongzhong Tong, Charity A Stratton, D Joshua Cameron, Shibo Tang, Kang Zhang.   

Abstract

Single nucleotide polymorphism (SNP), rs11200638, in the promoter of HTRA1 has recently been shown to increase the risk for AMD. In order to investigate the association of this HTRA1 polymorphism and the bilaterality of AMD, we genotyped rs11200638 in control, unilateral, and bilateral advanced AMD patients. The A allele for SNP rs11200638 in HTRA1, was significantly more prevalent in bilateral wet AMD and GA patients than in unilateral groups (p=.02 and p=.03, respectively). The homozygote odds ratios of bilateral wet AMD and GA are significantly greater than those seen in unilateral groups (twofold and threefold increase, respectively). This finding is consistent with the role of HTRA1 in AMD pathogenesis and will help aid in the clinical management and prognosis of AMD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206206     DOI: 10.1016/j.visres.2007.10.014

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  18 in total

Review 1.  Retinal remodeling.

Authors:  B W Jones; M Kondo; H Terasaki; Y Lin; M McCall; R E Marc
Journal:  Jpn J Ophthalmol       Date:  2012-05-30       Impact factor: 2.447

Review 2.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

Review 3.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

4.  Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian population.

Authors:  Mohammad Askari; Amin Reza Nikpoor; Fazel Gorjipour; Mohsen Mazidi; Mohammad Hosein Sanati; Hajar Aryan; Alireza Irani; Khalil Ghasemi Falavarjani; Hossein Nazari; Kazem Mousavizadeh
Journal:  Rep Biochem Mol Biol       Date:  2015-10

5.  Resveratrol inhibits mTOR signaling by targeting DEPTOR.

Authors:  Meilian Liu; Feng Liu
Journal:  Commun Integr Biol       Date:  2011-07-01

6.  ARMS2 interference leads to decrease of proinflammatory mediators.

Authors:  Fanxing Zeng; Min Zhang; Yiting Xu; Haifeng Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-20       Impact factor: 3.117

7.  Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L.

Authors:  Anping Wang; Meilian Liu; Xianling Liu; Lily Q Dong; Randolph D Glickman; Thomas J Slaga; Zhiguang Zhou; Feng Liu
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

8.  Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR.

Authors:  Meilian Liu; Sarah Ann Wilk; Anping Wang; Lijun Zhou; Rui-Hong Wang; Wataru Ogawa; Chuxia Deng; Lily Q Dong; Feng Liu
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

9.  Influence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population.

Authors:  Fernando Cruz-Gonzalez; Lucia Cabrillo-Estevez; Vanesa Rivero-Gutierrez; Ana Sanchez-Jara; Lourdes De Juan-Marcos; Rogelio Gonzalez-Sarmiento
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

10.  Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

Authors:  Michael T Andreoli; Margaux A Morrison; Ben J Kim; Ling Chen; Scott M Adams; Joan W Miller; Margaret M DeAngelis; Ivana K Kim
Journal:  Am J Ophthalmol       Date:  2009-10-01       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.